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Abstract
Activated Raf kinases and Rac GTPases were shown to cooperate in the oncogenic transformation of fibroblasts, which
is characterised by the disassembly of the cellular actin cytoskeleton, a nearly complete loss of focal adhesion complexes
and deregulated cell proliferation. This is surprising since the Rac GTPase induces actin structures and the adhesion of
suspended cells to extracellular matrix proteins. NIH 3T3 cells expressing a hydroxytamoxifen-inducible oncogenic c-Raf-
1^oestrogen receptor fusion protein (c-Raf-1-BxB-ERTM, N-BxB-ERTM cells) undergo morphological transformation upon
stimulation of the Raf kinase. We show that treatment with the Rac, Rho and Cdc42 activating Escherichia coli toxin
CNF1 or coexpression of an activated RacV12 mutant partially inhibits and reverses the disassembly of cellular actin
structures and focal adhesion complexes by oncogenic Raf. Activation of the Rac GTPase restores actin structures and
focal adhesion complexes at the cellular boundary, leading to spreading of the otherwise spindle-shaped Raf-transformed
cells. Actin stress fibres, however, which are regulated by the function of the Rho GTPase, are disassembled by oncogenic
Raf even in the presence of activated Rac and Rho. With respect to the RacV12-mediated spreading of Raf-transformed
cells, we postulate an anti-oncogenic function of the activated Rac. Another feature of cell transformation is the
deregulation of cell cycle control. NIH 3T3 cells expressing high levels of the c-Raf-1-BxB-ERTM protein undergo a cell
cycle arrest upon stimulation of the oncogenic Raf kinase. Our results show that in N-BxB-ERTM-RacV12 cells the
expression of the activated RacV12 mediates cell proliferation in the presence of high-intensity Raf signals and high levels
of the Cdk inhibitor p21Cip1. These results indicate a pro-oncogenic function of the Rac GTPase with respect to the
deregulation of cell cycle control. > 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Oncogenic transformation of ¢broblast cells is
characterised by deregulated cell proliferation and
profound morphological changes. The deregulation
of cell proliferation enables the transformed cell to
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survive and proliferate in an environment lacking
external factors necessary for cell cycle progression
and cell survival. The morphological changes in£u-
ence the attachment of the ¢broblasts to the extra-
cellular matrix such that the oncogenic cells have lost
most of their adhesion contacts. Both properties to-
gether enable cells to migrate out of their natural
tissues and form metastasis, a hallmark of malignant
cancer. The c-Raf-1 kinase is a downstream e¡ector
of di¡erent mitogens and constitutive Raf activation
is oncogenic [1]. Depending on the strength and du-
ration of the Raf signal it exerts mitogenic or cell
cycle inhibitory e¡ects. High-intensity Raf signals in-
hibit DNA synthesis and mitosis by the induction of
the cdk inhibitor p21Cip1, whereas low-intensity Raf
signals are su⁄cient to initiate DNA synthesis in
arrested NIH 3T3 ¢broblasts in the absence of exter-
nal growth factors [2^6]. In the presence of high-in-
tensity Raf signals it is proposed that a second co-
operating oncogene is necessary to overcome the cell
cycle block mediated by p21Cip1. Proteins cooperat-
ing with Raf are the Myc transcriptional regulator
and Rho and Rac GTPases [7^12]. The Ras GTPase
is an upstream activator of Raf and constitutive ac-
tivation of Ras is highly oncogenic [1,13]. Both the
Rho and Rac GTPases cooperate with activated Raf
proteins in cell transformation and are necessary for
cell transformation by oncogenic Ras [8^12]. This is
surprising since Rho and Rac are key regulators of
the cellular actin ¢lament and focal adhesion com-
plexes [14], structures which are disassembled by the
oncogenic action of Ras and Raf proteins. The for-
mation of actin structures and the clustering of in-
tegrins to form focal adhesion complexes has been
shown to be regulated by the members of the Rho
family of small GTPases [14]. Actin stress ¢bres are
induced by Rho activity, whereas the Rac and Cdc42
GTPases induce actin structures at the cellular
boundary called lamellipodia and ¢lopodia. The at-
tachment of cells to the extracellular matrix, a pro-
cess called cell spreading, has been shown to be
strongly in£uenced by the action of the Rac and
Cdc42 proteins on integrin clustering [15,16]. This
paradox could be explained in the way that the ac-
tion of the Rho and Rac proteins might contribute to
the deregulation of cell proliferation, whereas their
action in the regulation of actin structures and focal
adhesion complexes is impaired by the oncogenic ac-
tivation of the Ras and Raf proteins. Recent data
demonstrate that the activated Rho protein inhibits
the induction of p21Cip1 by Ras [17]. Here we have
addressed the question how constitutive Rac activity
in£uences the morphological transformation and cell
cycle progression of NIH 3T3 cells transformed by
oncogenic c-Raf-1.
2. Materials and methods
2.1. Cell culture and transfections
NIH 3T3, N-EHneo, N-BxB-ERTM-Cl-1 and N-
BxB-ERTM-RacV12 were grown in Dulbecco’s modi-
¢ed Eagle medium (Gibco) supplemented with Glu-
cose (Gibco), L-Glutamine (Gibco), 10% foetal calf
serum (Hyclone), 100 units/ml penicillin (Gibco) and
100 Wg/ml streptomycin (Gibco). The cells were in-
cubated at 37‡C, 5% CO2 and 90% humidity. 6 Wg/ml
puromycin (Sigma) was added to the culture medium
for puromycin selection and the maintenance of pur-
omycin resistant cell lines. Cells were induced with
hydroxytamoxifen by addition of a solution of 1 mM
OHT in ethanol to the medium to a ¢nal concentra-
tion of 200 nM (5000U dilution). For CNF1 treat-
ment GST-CNF1 was added to a ¢nal concentration
of 300 ng/ml. NIH 3T3 cells were transfected with a
high-e⁄ciency liposome transfection method employ-
ing the Lipofectamine reagent supplied by Gibco (6 Wl
Lipofectamine/1.5 Wg DNA). For the generation of
the N-BxB-ERTM-RacV12 cells 2U105 NIH 3T3
cells were seeded in a well of a six-well plate and
transfected with 0.5 Wg of the pBabe-puro-BxB-
ERTM vector [2] and 1.0 Wg of pEXV-Val12-Rac1-
myc tag vector [18,19]. Cell clones were isolated by
puromycin selection in the absence of OHT. For the
generation of N-EHneo cells 2U105 NIH 3T3 cells
were seeded in a well of a six-well plate and trans-
fected with 1.5 Wg of the EHneo plasmid [20] direct-
ing the expression of a v-Raf protein. Foci of trans-
formed cells were isolated by ring cloning and
puri¢ed from untransformed cells by soft agar clon-
ing.
2.2. Immuno£uorescence staining
Cells were seeded on glass cover slides and ¢xed in
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a 3.5% paraformaldehyde solution for 20 min at 4‡C.
After washing three times with PBS (Gibco) the cells
were permeablised by treatment with PBS containing
0.1% Triton X-100 (Sigma) for 10 min at room tem-
perature. The cells were washed three times with PBS
and incubated in the presence of a monoclonal
mouse anti-vinculin antibody (Sigma, hVIN-1, di-
luted 1:300) for 1 h. After washing three times
with PBS the cells were incubated in the presence
of polyclonal tetramethylrhodamine-isothiocyanate
(TRITC)-conjugated goat anti-mouse antibodies (Di-
anova, 1:100 dilution) and £uorescein isothiocyanate
(FITC)-conjugated phalloidin (Molecular Probes,
Eugene, OR; 1:15 dilution) for 45 min.
2.3. Immunoblotting
Immunoblotting experiments were performed as
described before [2]. The following antibodies were
used: Myc 9E10 (mouse monoclonal, 2 Wg/ml);
mouse oestrogen receptor HL7 (rabbit polyclonal,
1:750); pRb G3-245 (mouse monoclonal, Pharmin-
gen, 1 Wg/ml), cyclin A C-19 (rabbit polyclonal, San-
ta Cruz, 1 Wg/ml); cyclin D1 PRAD1 (rabbit poly-
clonal, Santa Cruz, 1 Wg/ml); p21Cip1 C-19 (rabbit
polyclonal, Santa Cruz, 1 Wg/ml); cdk4 C-22 (rabbit
polyclonal, Santa Cruz, 1 Wg/ml); phospho p44/p42
MAP kinase (Erk 1,2) Thr202/Tyr204 (rabbit poly-
clonal, New England Biolabs, 1:500).
3. Results
Analysis employing NIH 3T3 cells stably express-
ing a hydroxytamoxifen (OHT) inducible oncogenic
c-Raf-1/oestrogen receptor fusion protein (c-Raf-1-
BxB-ERTM, N-BxB-ERTM cells) has shown, that con-
stitutive activation of the c-Raf-1 kinase is su⁄cient
to transform NIH 3T3 mouse ¢broblast cells [2,3].
Low-intensity Raf signals induce deregulated cell
proliferation in the absence of external growth fac-
tors [2,3]. In contrast, a constitutive high-intensity
Raf signal, as it is generated by OHT treatment of
N-BxB-ERTM-Cl-1 cells, blocks cell cycle progression
[3]. Morphologically the activation of the oncogenic
c-Raf-1-BxB-ERTM kinase in NIH 3T3 cells leads to a
disassembly of the actin ¢laments and a nearly com-
plete loss of integrin-based focal adhesion complexes
(Fig. 1B). With respect to the morphological trans-
formation we found that cells exposed to high-inten-
sity Raf signals, such as OHT treated N-BxB-ERTM-
Cl-1 cells, have a much more transformed phenotype,
than cells which were exposed to a low-intensity Raf
signal, such as N-EHneo cells (Fig. 1A). Adhesion of
cells to extracellular matrices is largely mediated by
members of the integrin family of transmembrane
receptors [21]. In contrast to untransformed NIH
3T3 cells, which are £at and not refractile, the spin-
dle-shaped transformed cells are refractile and only
weakly attached to the tissue culture plate by a few
integrin-based focal adhesion complexes at the end of
the spindles (Fig. 1A,B).
To analyse the in£uence of Rho GTPase activation
on Raf-transformed NIH 3T3 mouse ¢broblasts we
employed the Escherichia coli toxin CNF1. As re-
cently discovered, CNF1 activates the Rho, Rac
and Cdc42 GTPases by deamidation of glutamine
residues [22,23]. Treatment of OHT induced N-
BxB-ERTM-Cl-1 cells with CNF1 reverses the trans-
formed morphology (Fig. 1A,B). The cells are £at-
tened but have ru¥ed membrane structures around
their nuclei (Fig. 1A). CNF1 also reverses the trans-
formed morphology of v-Raf (N-EHneo) (Fig. 1A)
and RasV12 transformed cells (data not shown).
Analysis of the actin ¢lament and integrin-based fo-
cal adhesion complexes shows that CNF1 restores
actin structures and integrin-based focal adhesion
complexes at the cellular boundary (Fig. 1B). How-
ever, the formation of Rho induced actin stress ¢bres
is inhibited in the presence of constitutive Raf activ-
ity (Fig. 1B). These data indicate that constitutive
activation of Rac by CNF1 overcomes the oncogenic
activity of Raf on the disassembly of actin structures
and integrin-based focal adhesion complexes at the
cellular boundary. Oncogenic Raf, however, inhibits
Rho-mediated formation of actin stress ¢bres.
To further characterise these ¢ndings we have an-
alysed if a constitutively activated RacV12 mutant
can rescue the morphological transformation of
NIH 3T3 cells by oncogenic Raf. We established
cell lines stably expressing the c-Raf-1-BxB-ERTM ki-
nase and the RacV12 protein (N-BxB-ERTM-RacV12-
1, 2). The expression of the transgenes was veri¢ed
by immunoblot analysis (Fig. 3A). In contrast to N-
BxB-ERTM-Cl-1 cells [3], which express only the in-
ducible oncogenic Raf kinase and become morpho-
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logically transformed upon OHT induction, the N-
BxB-ERTM-RacV12 clones retain their £at morphol-
ogy following OHT addition (Fig. 2A). The Raf ki-
nase mediates the phosphorylation of the Erk kinases
by activating the Mek kinase [1]. Compared to wild-
type NIH 3T3 cells, all three cell lines exhibit high
amounts of phosphorylated Erk kinases in the pres-
ence of OHT (Fig. 3A), indicating that the oncogenic
c-Raf-1-BxB-ERTM kinase has been activated by
OHT treatment. Although N-BxB-ERTM-RacV12
cells retain a £at morphology the cell structure
changes in that these cells exhibit ru¥ed membrane
structures around their nuclei (Fig. 2A). Analysis of
the actin structures in N-BxB-ERTM-Rac-V12-1 cells
in the absence and presence of OHT revealed that
the actin stress ¢bres were disassembled by the activ-
ity of the oncogenic c-Raf-1 kinase (Fig. 2B). Actin
structures and integrin-based focal adhesion com-
plexes at the cellular boundary, however, were not
altered (Fig. 2B). Taken together these experiments
show that oncogenic Raf is able to block the forma-
tion of Rho-mediated actin stress ¢bres, but is not
able to overcome the activity of RacV12, mediating
actin structures and integrin-based focal adhesion
complexes at the cellular boundary.
Our results show that activated Rac proteins par-
tially inhibit morphological Raf transformation by
mediating cell spreading. This is a surprising result
since Rac activity is required for Ras transformation,
C
Fig. 1. Escherichia coli toxin CNF1 partially reverses the mor-
phology of Raf-transformed cells. (A) NIH 3T3 cells stably ex-
pressing the c-Raf-1-BxB-ERTM fusion protein (N-BxB-ERTM-
Cl-1) exhibit a transformed morphology upon induction of the
oncogenic Raf kinase by hydroxytamoxifen. Addition of CNF1
to N-BxB-ERTM-Cl-1 cells in the presence of OHT reverses the
transformed spindle-shaped rounded morphology towards £at
and adherent cells. CNF1 also reverses the transformed mor-
phology of NIH 3T3 cells stably expressing an oncogenic v-Raf
protein (N-EHneo). (B) Immuno£uorescence staining of the ac-
tin structure and focal adhesion complexes of N-BxB-ERTM
cells in the presence and absence of OHT and CNF1. Prolifer-
ating N-BxB-ERTM-Cl-1 cells, untreated, and treated with
OHT, CNF1 and OHT/CNF1 were ¢xed with paraformalde-
hyde and stained with FITC^phalloidin (green) for their actin
structures and with mouse anti-vinculin/TRITC^goat anti-
mouse antibodies (red) for their integrin-based focal adhesion
complexes. Vinculin is present in integrin-based focal adhesion
complexes [14]. The stained cells were analysed with the help of
a £uorescence microscope.
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and activated Rac and Raf mutants cooperate in the
oncogenic transformation of ¢broblasts as analysed
by focus formation assays [8^12]. We have therefore
asked the question whether constitutive Rac signals
might contribute to the deregulation of cell cycle
control mechanisms, an other hallmark of oncogenic
transformation. Low-intensity Raf signals have been
shown to induce cell proliferation, whereas high con-
stitutive Raf signals, as those generated in OHT
treated N-BxB-ERTM-Cl-1 cells, block cell cycle pro-
gression by the induction of the expression of the
p21Cip1 cdk inhibitor [2,3]. A read-out system for
Raf signal intensities is the degree of Erk phosphor-
ylation. N-BxB-ERTM-Cl-1 cells exhibit high levels of
phosphorylated Erk kinases and p21Cip1, when in-
duced with OHT (Fig. 3A,B). The high Raf signals
in N-BxB-ERTM-Cl-1 cells cause a down-regulation
of pRb hyper-phosphorylation as documented by the
loss of the slower migrating pRb-pp proteins (Fig.
3A). Flow cytometry analysis revealed that the cells
arrest in G1 and G2/M phase of the cell cycle (Fig.
3C). By analysing the phosphorylation of the Erk1, 2
proteins we found that OHT induced N-BxB-ERTM-
RacV12-1 cells exhibit Raf signal intensities compa-
rable to the signals in N-BxB-ERTM-Cl-1 cells (Fig.
3A,B). The high-intensity signals lead in the case of
N-BxB-ERTM-Cl-1 and N-BxB-ERTM-RacV12 cells
to the expression of high levels of the cdk inhibitor
p21Cip1 (Fig. 3A,B). In contrast to N-BxB-ERTM-Cl-
1 cells, however, N-BxB-ERTM-RacV12 cells are able
to proliferate in the presence of the high-intensity
Raf signals and elevated levels of the p21Cip1 cdk
inhibitor (Fig. 3A,B,C). The pRb protein is a cellular
phosphorylation target for cdk activity [24,25]. Cdk-
mediated pRb phosphorylation is an essential step in
the regulation of the G1/S transition. Despite the
high levels of p21Cip1 expression the pRb hyperphos-
phorylation is not a¡ected (Fig. 3A), indicating that
p21Cip1 does not inhibit the cdk activity in OHT
treated N-BxB-ERTM-RacV12 cells. We have con-
¢rmed these data by analysing the activity of the
Fig. 2. Activated RacV12 inhibits morphological transformation
by oncogenic c-Raf-1. (A) The morphology of N-BxB-ERTM-
Cl-1 (N-BxB-ERTM) and N-BxB-ERTM-RacV12-1, 2 cells was
analysed by phase-contrast microscopy in the presence of the
c-Raf-1-BxB-ERTM activating hydroxoytamoxifen. (B) Actin
structure of N-BxB-ERTM-RacV12-1 cells in the presence and
absence of OHT. N-BxB-ERTM-RacV12-1 cells were cultured in
the presence and absence of OHT, ¢xed with paraformaldehyde
and stained with FITC-conjugated phalloidin (green) for their
actin structures and with mouse anti-vinculin/TRITC^goat anti-
mouse antibodies (red) for their integrin-based focal adhesion
complexes. Vinculin is present in integrin-based focal adhesion
complexes [14]. The cells were analysed by £uorescence micros-
copy.
C
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cdk2 kinase, which is not a¡ected in the presence of
the high levels of p21Cip1 in N-BxB-ERTM-RacV12-1
cells (data not shown). Consistent with the results on
the pRb phosphorylation status, the cells do not
cease the cell cycle as shown by the expression cyclin
A protein, whose expression correlates with the pro-
liferative status of cells (Fig. 3A), and the cell cycle
distribution of N-BxB-ERTM-RacV12-1 cells (Fig.
3C). Even in the presence of OHT N-BxB-ERTM-
RacV12-1 cells exhibit a signi¢cant proportion of
cells in S phase, compared to the complete loss of
the S-phase population in OHT-treated N-BxB-
ERTM-Cl-1 cells (Fig. 3C).
4. Discussion
We show that the mutational activation of the Rac
GTPase in£uences the transformation of Raf in dif-
ferent ways. RacV12 partially inhibits the morpho-
logical transformation and favours deregulated cell
proliferation in the presence of high p21Cip1 cdk in-
hibitor levels. The mechanisms by which the onco-
genic Raf kinase mediates morphological transfor-
mation are unknown. Our results demonstrate
distinct sensitivities of individual cellular structures
towards the constitutive activation of Raf signals.
Actin stress ¢bre formation is regulated by the Rho
GTPase [14,26]. Even under conditions where the
CNF1 toxin has activated the Rho protein, the on-
Fig. 4. Co-expression of activated Rac and Raf proteins impairs
the oncogenic activity of Raf to disassemble focal adhesion
complexes and actin structures at the cellular boundary. The
¢nding that mutational activation of Rac partially reverses the
morphological oncogenic activity of Raf indicates that during
Raf-induced oncogenic transformation upstream activators of
Rac are inhibited, which then cause the severe morphological
changes found in transformed ¢broblasts. We found actin stress
¢bres destroyed by oncogenic Raf even in the presence of
CNF1-activated Rho. This could be explained by the fact that
oncogenic Raf inhibits downstream events of Rho signalling,
regulating the formation of actin stress ¢bres.
Fig. 3. Activated RacV12 allows cell proliferation and retinoblastoma protein (pRb) hyperphosphorylation in the presence of high lev-
els of the cdk inhibitor p21Cip1. (A) Immunoblot analysis of the expression of the transgene products c-Raf-1-BxB-ERTM and RacV12,
the phosphorylation status of the Erk 1, 2 kinases and the retinoblastoma protein pRb (the hyperphosphorylated form is designated
as pRb-pp), and the cell cycle machinery components cyclin A and p21Cip1. Equal amounts of total lysates of N-BxB-ERTM-RacV12-1
(1), N-BxB-ERTM-RacV12-2 (2), N-BxB-ERTM-Cl-1 (Cl-1) and NIH 3T3 cells (N) were separated by SDS^polyacrylamide gel electro-
phoresis and blotted onto nitrocellulose or PVDF membranes. The expression of the indicated proteins was analysed by immunodetec-
tion. To document equal protein loading the expression of the cdk4 protein has been analysed. The di¡erent cell lines were subcon£u-
ent and cultured under high serum conditions (10%). In order to analyse the activation of oncogenic c-Raf-1 protein, c-Raf-1-BxB-
ERTM-expressing cell lines were cultured for 36 h in the presence of OHT. (B) Expression of p21Cip1 and cyclin D1 in N-BxB-ERTM-
Cl-1 and N-BxB-ERTM-RacV12-1 cells in the presence and absence of 4-hydroxytamoxifen. The cells were cultured subcon£uent under
high serum (10%) conditions. The OHT-induced cells were incubated for 36 h in the presence of the inducer. Total protein lysates
were separated by SDS^polyacrylamide gel electrophoresis and blotted onto nitrocellulose and PVDF membranes. The expression of
the indicated proteins was analysed by immunodetection. In order to verify equal protein loading the expression of the cdk4 and
Erk1, 2 kinases was analysed. In order to control the induction of the c-Raf-1-BxB-ERTM kinase by OHT the phosphorylation status
of the Erk1, 2 kinase was analysed with the help of phospho Erk-speci¢c antibodies. (C) Subcon£uent N-BxB-ERTM-Cl-1 and N-BxB-
ERTM-RacV12-1 cells were cultured under high serum conditions in the absence and presence of OHT. The ethanol-¢xed cells were
stained with propidium iodide and analysed for their DNA content by £ow cytometry as desired earlier [2]. The distribution of cells
in the di¡erent phases of the cell cycle were quanti¢ed with the computer program ModFit (Verity Software).
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cogenic Raf kinase causes a disassembly of the stress
¢bre structures (Fig. 1B). This indicates an inhibitory
mechanism downstream of the Rho signal transducer
(Fig. 4). This conclusion was recently con¢rmed by a
study showing that sustained Raf-MAP kinase sig-
nalling downregulates ROCK and Rho-kinase, two
Rho e¡ectors required for actin stress ¢bre formation
[27]. In the presence of activated Rac, however, the
oncogenic Raf protein is not able to disassemble ac-
tin structures and focal adhesion complexes at the
cellular boundary (Fig. 2B). These data suggest
that oncogenic Raf inhibits upstream activators of
Rac in order to impair the Rac-mediated adhesion
of cell to the extracellular matrix (Fig. 4). Similar
results were found in epithelial cells where sustained
Raf/MAP kinase signalling causes transcriptional
down-regulation of Tiam1, an activator of Rac
[28]. Expression of RacV12 in mesenchymal
RasV12 or RafCAAX-transformed epithelial cells re-
stores the epithelial phenotype [28]. A down-regula-
tion of Tiam1 expression could also be detected in N-
BxB-ERTM and N-BxB-ERTM-RacV12 cells follow-
ing OHT stimulation (data not shown).
Previous studies convincingly demonstrate that ac-
tivated Rac GTPases enhance oncogenic RafCAAX
and Ras-triggered morphological transformation
[8,10,11]. These studies are in contrast to the data
presented in this study and to the data by others
described above [28]. The signal strength turned out
to be a critical parameter in the decision of a cell to
proliferate or to cease the cell cycle [29]. Therefore, a
possible explanation for the discrepancy could be a
di¡erent Rho and Rac signal intensity in the studies.
It remains to be analysed whether a modulation of
the Rho or Rac signal strength could in one case
enhance morphological transformation and in the
other case partially inhibit it. Our experiments are
the only studies which have employed the activated
Raf^oestrogen receptor fusion protein. Since the
treatment of the viral Raf-transformed N-EHneo
cells with CNF-1 partially reverted the transformed
morphology (Fig. 1A) and RacV12 was shown to
revert the transformed morphology of RafCAAX
transformed cells [28], we exclude the use of the c-
Raf-1-BxB-ERTM protein as an explanation for the
di¡erences in morphological cell transformation.
High-intensity Raf signals mediate a cell cycle ar-
rest by the upregulation of the cdk inhibitor p21Cip1.
In the presence of RacV12 expression, high-intensity
Raf signals were unable to mediate a proliferative
arrest (Fig. 3). In contrast to the Rac related Rho
GTPase, which was shown to inhibit the upregula-
tion of p21Cip1 expression [17], the activated Rac
protein does not in£uence the expression of the cdk
inhibitor (Fig. 3A,B). Despite the high levels of the
cdk inhibitor, the activity of cdk kinases is not in£u-
enced since a cellular phosphorylation target, the
pRB protein, is highly phosphorylated (Fig. 3A)
and we detect cdk2 activity in in vitro complex ki-
nase assays (data not shown). These data indicate
that Rac activity blocks the inhibitory action of
p21Cip1 on cdk kinase activity.
The overall relation between cdks, cyclins, and cdk
inhibitors determines if p21Cip1 will act as an inhib-
itor. Since both RacV12 and Raf induce the expres-
sion of cyclin D1 [2,30], we have especially analysed
the expression of this cyclin. A synergistic e¡ect of
both activated oncogenes on cyclin D1 expression
would have been able to super-induce the cyclin D1
expression and shift the complex equilibrium of the
cell cycle components in the direction of cell cycle
progression. Comparison of Raf-induced with Raf/
Rac-induced cells did not reveal any di¡erences in
the induction levels of cyclin D1 (Fig. 3B). Therefore,
a synergistic activation and a role of cyclin D1 in the
rescue mechanism can be excluded. A detailed anal-
ysis of the expression of all components of the cell
cycle machinery in N-BxB-ERTM-Cl-1 and N-BxB-
ERTM-RacV12-1 cells may shed light on the mecha-
nism of how cell proliferation is mediated in OHT
induced N-BxB-ERTM-RacV12 cells.
Here we show that RacV12 has anti- and pro-on-
cogenic in£uences on the transformation by Raf. It
will be interesting to analyse in detail which of the
di¡erent pathways mediates the divers functions of
RacV12 on cell transformation. Separate e¡ector
pathways for cell spreading and the deregulation of
cell cycle control might exist. Delineation of these
pathways should help to ¢nd new strategies for the
development of anti-cancer drugs, targeting the mor-
phological transformation of cells.
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